| Items 201 ~ 220 of 25944, Page 11 of 1298 |
| 201. |
Statement from FDA Commissioner and director of the Center for Drug Evaluation and Research on the FDA¡¯s ongoing investigation into valsartan and ARB class impurities and the agency¡¯s steps to address the root causes of the safety issues - 01/25/2019
U.S. FOOD & DRUG ADMINISTRATION |
| 202. |
RSNA in Brief-Q4 2018 - 01/24/2019
Radiological Society of North America |
| |
To keep media informed about its current activities, the Radiological Society of North America (RSNA) distributes brief quarterly updates. For more information about any of these activities or to interview a spokesperson, contact RSNA Media Relations staff. |
| 203. |
FDA statement from Commissioner announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications - 01/24/2019
U.S. FOOD & DRUG ADMINISTRATION |
| |
Risk Evaluation and Mitigation Strategy (REMS) |
| 204. |
Lung Cancer Screening Guidelines for Current or Former Smokers - 01/24/2019
American Cancer Society |
| |
American Cancer Society guidelines recommend yearly lung cancer screening for people who meet certain criteria that put them at higher risk for developing the disease. |
| 205. |
Medtronic to Acquire EPIX Therapeutics, Expanding Its Cardiac Ablation Portfolio - 01/24/2019
Medtronic |
| |
DiamondTemp Ablation System Represents Disruptive RF Innovation |
| 206. |
Abbott Reports 2018 Results and Issues Strong Forecast for 2019 - 01/23/2019
Abbott |
| |
Full-year 2018 sales growth of 11.6 percent; organic sales growth of 7.3 percent / Issues financial outlook for 2019, reflecting double-digit EPS growth and 6.5 to 7.5 percent organic sales growth |
| 207. |
Statement from FDA Commissioner, Director of the Center for Devices and Radiological Health, on latest steps to strengthen FDA¡¯s 510(k) program for premarket review of medical devices - 01/22/2019
U.S. FOOD & DRUG ADMINISTRATION |
| 208. |
Artificial Intelligence Shows Potential for Triaging Chest X-rays - 01/22/2019
Radiological Society of North America |
| |
Researchers trained an artificial intelligence system to interpret and prioritize abnormal chest X-rays with critical findings. / Chest X-rays account for 40 percent of all diagnostic imaging worldwide and create significant backlogs at health care facilities. / The AI system distinguished abnormal from normal X-rays with high accuracy. |
| 209. |
U.S. FDA Accepts sNDAs for PIFELTRO¢â (doravirine) and DELSTRIGO¢â (doravirine/lamivudine/tenofovir disoproxil fumarate) - 01/22/2019
MERCK |
| |
Potential New Indication Would Expand Use to Allow Treatment-Experienced Adults Living with HIV-1 Whose Virus is Suppressed to Switch to PIFELTRO (in Combination with Other Antiretrovirals) or DELSTRIGO |
| 210. |
Patient-Level Survival Analysis Demonstrates No Link Between Paclitaxel Dose and Mortality in Patients Treated with IN.PACT Admiral DCB - 01/22/2019
Medtronic |
| |
Data Presented Today at LINC Reiterate Commitment to Patient Safety and Data Transparency |
| 211. |
Study: Oncologists Want More Education About LGBTQ Issues - 01/22/2019
American Cancer Society |
| |
A survey of oncologists finds that most say they don¡¯t know enough about how to treat people in the lesbian, gay, bisexual, transgender, and queer/questioning (LGBTQ) community, but want to learn more. |
| 212. |
Trampoline parks may cause more severe trauma than at home trampoline use - 01/22/2019
American Academy of Orthopaedic Surgeons |
| |
New research compares injuries sustained at commercial jump parks versus home trampolines |
| 213. |
Lifestyle Choices May Help Glaucoma Patients Preserve Eyesight - 01/22/2019
American Academy of Ophthalmology |
| |
American Academy of Ophthalmology offers advice on how people can take control of their health beyond medications and surgery |
| 214. |
Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation - 01/21/2019
Abbott |
| |
With approval of the TactiCath¢â Contact Force Ablation Catheter, Sensor Enabled¢â, Abbott is helping more physicians integrate ablation with 3D mapping to advance the treatment of people with atrial fibrillation |
| 215. |
New Data Reinforce Benefits of Abbott¡¯s BurstDR¢â Spinal Cord Stimulation for People Living with Chronic Pain - 01/19/2019
Abbott |
| |
Data from two recent studies presented at NANS 2019 demonstrate key benefits of BurstDR¢â stimulation / Microdosing BurstDR stimulation at lowest effective energy allows patients to manage their pain without the burden of recharging their devices / Additional data further showed switching from other types of SCS therapies to Abbott¡¯s BurstDR stimulation significantly reduced pain and the need for opioid medication |
| 216. |
ACS Cancer Prevention Blueprint Targets Controllable Risk Factors - 01/18/2019
American Cancer Society |
| |
This second chapter in the American Cancer Society Cancer Control Blueprint describes what we know about risk factors for cancer. It provides strategies people can use to help avoid those risk factors. It also offers strategies that cities, states, and communities can use to help people avoid them. It''s co-authored by staff researcher Susan Gapstur, PhD, MPH, senior vice president of Behavioral and Epidemiology Research. |
| 217. |
American Academy of Orthopaedic Surgeons approves clinical practice guideline for management of acute compartment syndrome - 01/17/2019
American Academy of Orthopaedic Surgeons |
| |
Evidence-based diagnosis and treatment recommendations for traumatic, severe limb injuries |
| 218. |
Statement from FDA Commissioner, on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths - 01/17/2019
U.S. FOOD & DRUG ADMINISTRATION |
| 219. |
World Cancer Day 2019: ¡®I Am and I Will.¡¯ - 01/17/2019
American Cancer Society |
| |
Monday, February 4th is World Cancer Day, when organizations and people around the world unite to raise awareness about cancer and work to make it a global health priority. |
| 220. |
Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery - 01/17/2019
Medtronic |
| |
Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids |
